KALA BIO, Inc. (KALA) NASDAQ
0.17
+0.0072(+4.42%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.17
+0.0072(+4.42%)
Currency In USD
| Previous Close | 0.16 |
| Open | 0.16 |
| Day High | 0.17 |
| Day Low | 0.15 |
| 52-Week High | 20.6 |
| 52-Week Low | 0.15 |
| Volume | 3.24M |
| Average Volume | 7.19M |
| Market Cap | 3.73M |
| PE | -0.03 |
| EPS | -5.64 |
| Moving Average 50 Days | 0.37 |
| Moving Average 200 Days | 3.81 |
| Change | 0.01 |
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents
Newsfile
Mar 11, 2026 3:18 PM GMT
Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA)Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Younet.ai, a
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
GlobeNewswire Inc.
Mar 11, 2026 10:30 AM GMT
Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within Two WeeksARLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) announces that it is ready to ship its first commercial
KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform “Researgency”
GlobeNewswire Inc.
Mar 04, 2026 11:30 AM GMT
Company launches initiative to become a dedicated AI infrastructure partner for the biotechnology industry — to deploy secure, on-premises AI systems directly within client environments where proprietary data never leaves the client’s controlPlatform